Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123M Hold
3,000,000
1.37% 18
2026
Q1
$158M Hold
3,000,000
1.96% 18
2025
Q4
$191M Hold
3,000,000
2.05% 19
2025
Q3
$209M Hold
3,000,000
2.28% 19
2025
Q2
$213M Hold
3,000,000
2.46% 19
2025
Q1
$190M Hold
3,000,000
2.38% 19
2024
Q4
$227M Hold
3,000,000
2.74% 19
2024
Q3
$265M Buy
3,000,000
+250,000
+9% +$19.6M 3.23% 18
2024
Q2
$207M Buy
2,750,000
+250,000
+10% +$23.2M 2.65% 19
2024
Q1
$235M Hold
2,500,000
2.82% 19
2023
Q4
$271M Hold
2,500,000
3.36% 15
2023
Q3
$239M Buy
2,500,000
+400,000
+19% +$41.1M 3.18% 18
2023
Q2
$232M Hold
2,100,000
3.05% 16
2023
Q1
$258M Hold
2,100,000
3.59% 17
2022
Q4
$246M Hold
2,100,000
3.63% 17
2022
Q3
$175M Hold
2,100,000
2.74% 20
2022
Q2
$215M Hold
2,100,000
2.8% 21
2022
Q1
$283M Hold
2,100,000
2.95% 20
2021
Q4
$350M Hold
2,100,000
3.32% 19
2021
Q3
$305M Hold
2,100,000
3.01% 19
2021
Q2
$324M Hold
2,100,000
3.09% 17
2021
Q1
$279M Hold
2,100,000
2.91% 19
2020
Q4
$297M Hold
2,100,000
3.04% 13
2020
Q3
$264M Hold
2,100,000
3.56% 12
2020
Q2
$206M Buy
2,100,000
+1,780,000
+556% +$164M 3.13% 19
2020
Q1
$26.5M Buy
+320,000
New +$29.8M 0.47% 20

Other funds holding NKE

Wellcome Trust's NKE Position: Q2 2026 in Review

Wellcome Trust held its Nike (NKE) position steady in Q2 2026 at 3,000,000 shares worth $123M. The position accounts for 1.37% of the portfolio, ranked #18.

Wellcome Trust first reported a position in NKE in Q1 2020 and has held it in 26 quarters since. The position peaked at $350M in Q4 2021. 637 funds tracked by Wall St. Rank hold NKE as of Q2 2026.

  • Wellcome Trust held 3,000,000 shares of Nike worth $123M as of Q2 2026.
  • Wellcome Trust left its Nike share count unchanged in Q2 2026.
  • Nike made up 1.37% of Wellcome Trust's portfolio in Q2 2026, its #18 holding.
  • Wellcome Trust first reported a position in Nike in Q1 2020 and has held it in 26 quarters since.
  • Wellcome Trust's Nike position peaked at $350M in Q4 2021.
  • 637 funds tracked by Wall St. Rank held Nike as of Q2 2026.

Based on Wellcome Trust's 13F filing for Q2 2026, filed 9 Jul 2026.